Showing results (261-270 of 288) with videos related to

Sort By:
Pageof 29
Journal of Clinical Gastroenterology|April 19, 2003
Triple combination of interferon alpha-2b, ribavirin, and amantadine for treatment of chronic hepatitis CZobair M Younossi, Kevin D Mullen, Sandra Hodnick, et al.
Cancer Treatment Reports|December 1, 1982
Cisplatin therapy in recurrent childhood brain tumorsA B Khan, B J D'Souza, M D Wharam, et al.
Breast Cancer Research and Treatment|October 16, 2019
The Jacki Jacket after mastectomy with reconstruction: a randomized pilot studyDonna L Berry, Traci M Blonquist, Barbara Halpenny, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 24, 2015
Polyethylenimine-based polyplex delivery of self-replicating RNA vaccinesThomas Démoulins, Panagiota Milona, Pavlos C Englezou, et al.
Thorax|November 20, 2001
Pulmonary (99m)Tc-DTPA aerosol clearance and survival in usual interstitial pneumonia (UIP)N Mogulkoc, M H Brutsche, P W Bishop, et al.
The Journal of General Virology|August 16, 2005
Identification of classical swine fever virus protein E2 as a target for cytotoxic T cells by using mRNA-transfected antigen-presenting cellsM Ceppi, M G M de Bruin, T Seuberlich, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic LipidsPavlos C Englezou, Cedric Sapet, Thomas Démoulins, et al.
International Journal of Radiation Oncology, Biology, Physics|October 15, 1995
Intraoperative electron beam radiation therapy: technique, dosimetry, and dose specification: report of task force 48 of the Radiation Therapy Committee, American Association of Physicists in MedicineJ R Palta, P J Biggs, J D Hazle, et al.
Clinical and Vaccine Immunology : CVI|June 26, 2009
Innate immune defenses induced by CpG do not promote vaccine-induced protection against foot-and-mouth disease virus in pigsM P Alves, L Guzylack-Piriou, V Juillard, et al.
Journal of Hepatology|February 24, 2001
A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapyZ M Younossi, K D Mullen, W Zakko, et al.
Pageof 29